At the last annual meeting of the Academy of Managed Care Pharmacy, several of us spoke on pharmaceutical research and development in the quickly emerging value-driven healthcare system. Topics focused on the impact of value-based benefit designs, comparative effectiveness research, and government policies on the development of new drugs and biologics:
Research and Development in the Current Healthcare System: An Overview
What Constitutes Medical Evidence in the Era of Comparative Effectiveness?
New Government Policies: Opportunities for Supporting Research and Development
Drug Discovery and Development in a Value-Driven Healthcare System
A Hypothetical Case: Current Drug R&D Process
Our presentations were published in a supplement issue of American Health & Drug Benefits, a peer-reviewed journal serving about 30,000 decision makers. To read the articles, which are approved for continuing education credit, click here.